These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7993719)

  • 21. Hydroxyethyl starch and risk of bleeding: the missing links.
    Shander A; Moskowitz D
    Anesth Analg; 2006 Mar; 102(3):968; author reply 968. PubMed ID: 16492868
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials.
    Kozek-Langenecker SA; Jungheinrich C; Sauermann W; Van der Linden P
    Anesth Analg; 2008 Aug; 107(2):382-90. PubMed ID: 18633012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen and bleeding: old molecule--new ideas.
    Nielsen VG; Levy JH
    Anesth Analg; 2007 Oct; 105(4):902-3. PubMed ID: 17898364
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of Hextend hemodilution on plasma coagulation kinetics in the rabbit: role of factor XIII-mediated fibrin polymer crosslinking.
    Nielsen VG
    J Surg Res; 2006 May; 132(1):17-22. PubMed ID: 16154147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Variations in ionized plasma calcium during the administration of a macromolecular expander solution].
    Glomaud D; Dauchy F; Wargnier MO; Hadjaje N; Salamagne JC
    Anesth Analg (Paris); 1978; 35(1):155-9. PubMed ID: 27998
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjusting surgical bleeding for dilutional effect of Hextend.
    Javidroozi M; Moskowitz DM; Shander A
    Transfusion; 2008 Nov; 48(11):2480-1. PubMed ID: 19054380
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemostasis and coagulation monitoring and management during liver transplantation.
    Dalmau A; Sabaté A; Aparicio I
    Curr Opin Organ Transplant; 2009 Jun; 14(3):286-90. PubMed ID: 19300254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxyethyl starch and blood coagulation.
    Booke M; Sielenkämper A; Wirtz S; Bone HG; Hinder F
    Eur J Anaesthesiol; 1999 Sep; 16(9):651-2. PubMed ID: 10549468
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply to 'HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial'.
    Standl T
    Eur J Anaesthesiol; 2009 Aug; 26(8):702-4. PubMed ID: 19318952
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of polidez on blood coagulation in patients with atherosclerosis of the major arteries].
    Shcherbinina SP
    Gematol Transfuziol; 1986 Dec; 31(12):10-3. PubMed ID: 3817413
    [No Abstract]   [Full Text] [Related]  

  • 31. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices.
    Ganter MT; Hofer CK
    Anesth Analg; 2008 May; 106(5):1366-75. PubMed ID: 18420846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of aprotinin on selected parameters of coagulation and drainage blood loss after cardiac operations in patients without coagulation disorders].
    Hirnle T; Stachurski A; Goździk W; Pelczar M; Wachnik J; Hirnle G; Milczarska J; Kustrzycki W
    Pol Merkur Lekarski; 2006 May; 20(119):543-6. PubMed ID: 16875158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of hydrolysine solution as plasma substitute for prevention of surgical shock].
    ABRAMOV VS
    Vestn Khir Im I I Grek; 1956 Nov; 77(11):101-7. PubMed ID: 13401678
    [No Abstract]   [Full Text] [Related]  

  • 34. Coagulopathy induced by colloid plasma expanders--search for an efficacious haemostatic intervention.
    Fenger-Eriksen C; Ingerslev J; Sørensen B
    Acta Anaesthesiol Scand; 2006 Aug; 50(7):899-900. PubMed ID: 16879481
    [No Abstract]   [Full Text] [Related]  

  • 35. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between the antigenicity of blood plasma substitute solutions prepared from heterogeneous protein material and their therapeutic effect.
    Paluska E; Stĕrba O
    Folia Biol (Praha); 1969; 15(5):389-94. PubMed ID: 5344442
    [No Abstract]   [Full Text] [Related]  

  • 37. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical experimentation with a new plasma substitute "Haemaccel"].
    Botassi P; Agnesini A
    Hospital (Rio J); 1968 Oct; 74(4):1323-5. PubMed ID: 5304163
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical pharmacology of plasma expanders].
    Zaffiri O; Mastroianni A; Contratti V; Francescato F
    Minerva Anestesiol; 1969 May; 35(5):589-95. PubMed ID: 5788281
    [No Abstract]   [Full Text] [Related]  

  • 40. Does Hextend impair coagulation compared to 6% hetastarch? An ex vivo thromboelastography study.
    Weeks DL; Jahr JS; Lim JC; Butch AW; Driessen B
    Am J Ther; 2008; 15(3):225-30. PubMed ID: 18496260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.